Monitoring vedolizumab and ustekinumab drug levels in patients with inflammatory bowel disease: hype or hope?
Dahham Alsoud, Séverine Vermeire, Bram Verstockt
Topics & Concepts
VedolizumabUstekinumabMedicineInflammatory bowel diseaseTherapeutic drug monitoringDrugIntensive care medicineUlcerative colitisCrohn's diseaseObservational studyDiseaseInfliximabInternal medicinePharmacologyInflammatory Bowel DiseaseBiosimilars and Bioanalytical MethodsMicroscopic Colitis